New hope for duchenne: Long-Term drug trial underway
NCT ID NCT04433234
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 26 times
Summary
This study looks at the long-term safety and effectiveness of a drug called DS-5141b in people with Duchenne muscular dystrophy (DMD). It includes 8 participants who already completed an earlier study of the same drug. Researchers will track side effects and measure changes in muscle function, breathing, and heart health over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DUCHENNE MUSCULAR DYSTROPHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Kobe University Hospital
Hyōgo, 650-0017, Japan
-
National Center of Neurology and Psychiatry
Tokyo, Kodaira-Shi, 187-8551, Japan
Conditions
Explore the condition pages connected to this study.